市場調查報告書
商品編碼
1637686
北美放射腫瘤學市場預測至 2031 年 - 區域分析 - 按類型和應用North America Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types and Application |
2023年北美放射腫瘤市值為40.4723億美元,預計2031年將達到104.0958億美元;預計2023年至2031年複合年成長率為12.5%。
癌症盛行率的增加推動了北美放射腫瘤學市場
癌症是對全世界社會產生重大影響的常見健康狀況之一。根據世界衛生組織(WHO) 的數據,癌症是全球主要死亡原因,到2023 年,癌症將導致970 萬人死亡,新增癌症病例將達到2000 萬,預計到2050 年,新增癌症病例將達到約3,500 萬。 7.8%、6.9%和6.8%。
癌症盛行率和發病率的不斷上升創造了對有效治療方案的需求。放射治療是癌症患者不斷發展的治療選擇之一,它利用高劑量的輻射(例如 X光、伽馬射線等)來殺死癌細胞,具有有效的效果。放射治療用於癌症的早期階段,各種類型的體外放射治療用於治療不同的癌症。例如,近距離放射治療用於治療乳癌、子宮頸癌、眼癌、攝護腺癌和頭頸癌。同樣,全身放射治療也稱為放射性碘,用於治療甲狀腺癌。放射治療可以在治療的任何時間使用,並且可以與其他治療方法結合使用,例如手術、化療、免疫治療等。因此,癌症盛行率的增加和腫瘤學放射治療的發展預計將推動放射腫瘤學市場的成長。
北美放射腫瘤學市場概況
在美國,所有癌症患者都可以廣泛使用放射治療,並且對放射腫瘤科醫師的需求不斷增加。由於醫療基礎設施的發達,這些專業人員的數量也不斷增加。儘管如此,美國臨床腫瘤學會估計全球約三分之二的癌症患者接受放射治療作為治療的一部分。到 2023 年,預計美國每年將有超過 100 萬名癌症患者接受放射治療。政府和醫療機構正在採取多項措施來鼓勵採用放射治療。 2020 年 6 月,美國放射腫瘤學會 (ASTRO) 推出了非轉移性子宮頸癌放射治療的新臨床指南。新指南的重點是精確實施放射治療的步驟和流程。
北美放射腫瘤學市場收入及 2031 年預測(百萬美元)
北美放射腫瘤學市場細分
北美放射腫瘤學市場按類型、應用和國家分類。
根據類型,北美放射腫瘤學市場分為體外放射治療和內照射放射治療。 2023 年,體外放射治療領域將佔據更大的市場佔有率。
從應用來看,北美放射腫瘤市場分為乳癌、攝護腺癌、肺癌、頭頸癌、子宮頸癌等。 2023 年,乳癌細分市場佔據最大的市場佔有率。
按國家/地區分類,北美放射腫瘤學市場分為美國、加拿大和墨西哥。 2023 年,美國在北美放射腫瘤學市場佔有率中佔據主導地位。
Varian Medical Systems Inc、Elekta AB、Accuray Incorporated、IBA Worldwide (Ion Beam Applications SA)、Becton Dickinson and Co、Perspective Therapeutics Inc、NTP RADIOISOTOPES、Mallinckrodt Plc、Provision Healthcare 和 Curium 是美國北方營運的一些領先公司美國放射腫瘤學市場。
The North America radiation oncology market was valued at US$ 4,047.23 million in 2023 and is expected to reach US$ 10,409.58 million by 2031; it is estimated to record a CAGR of 12.5% from 2023 to 2031.
Increasing Prevalence of Cancer Fuels North America Radiation Oncology Market
Cancer is one of the common health conditions significantly impacting society worldwide. According to the World Health Organization (WHO), cancer is the leading cause of death worldwide, accounting for 9.7 million deaths and 20 million new cancer cases in 2023 and it is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer and leading cause of the death globally followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer accounting for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total deaths respectively.
The increasing prevalence and incidence of cancer creates demand for effective treatment options. Radiotherapy is one of evolving treatment options for cancer patients with effective outcome which utilizes the high doses of radiation such as X-rays, gamma rays, and others to kill the cancerous cells. Radiotherapy is used in the early stages of cancer and various types of external beam radiotherapy are used for the treatment of different cancers. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Similarly, Systemic radiation therapy is also known as radioactive iodine and is used for treatment of thyroid cancer. Radiation therapy can be used at any point in the treatment and can be combined with other treatments such as surgery, chemotherapy, immunotherapy and others. Therefore, increasing prevalence of cancer and evolution of radiotherapy in oncology is expected to drive the growth of radiation oncology market.
North America Radiation Oncology Market Overview
Radiation therapy is widely available for all cancer patients in the US, and the need for radiation oncologists is continuously on the rise. The number of these professionals also increases continuously owing to the developed healthcare infrastructure. Nevertheless, the American Society of Clinical Oncology approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2023, over 1 million cancer patients in the US are projected to undergo radiation therapy annually. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy.
North America Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)
North America Radiation Oncology Market Segmentation
The North America radiation oncology market is categorized into types, application, and country.
Based on types, the North America radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.
In terms of application, the North America radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.
By country, the North America radiation oncology market is segmented into the US, Canada, and Mexico. The US dominated the North America radiation oncology market share in 2023.
Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Perspective Therapeutics Inc, NTP RADIOISOTOPES, Mallinckrodt Plc, Provision Healthcare, and Curium are some of the leading companies operating in the North America radiation oncology market.